Received Apr 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 4N222 | — |
injected the diluent, instead of reconstitute it; injected the diluent, instead of reconstitute it; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received MMR (Priorix) (batch number 4N222, expiry date 13-SEP-2026) for prophylaxis. On 09-APR-2025, the patient received Priorix. On 09-APR-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: injected the diluent, instead of reconstitute it) and inappropriate dose of vaccine administered (Verbatim: injected the diluent, instead of reconstitute it). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-APR-2025 and 17-APR-2025 On 15th April 2025, Pharmacist called and reported that he/she was using the Priorix, the MMR vaccine, and realized that he/she had just injected the diluent instead of reconstituting it, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered.